Profile
Kevin S.
Sly has served as our senior vice president and chief business officer since March 2003.
Mr. Sly has over 20 years of experience in the design, development and management of products, services and businesses incorporating biomedical and pharmaceutical technologies.
Mr. Sly joined Advancis in February 2002 with 22 years of experience designing, developing, and managing products and services that incorporate biomedical and pharmaceutical technologies.
He brings skills and experience in strategic planning, development of new business, new technology, business intelligence, market research, new markets development, and marketing communications in both start-up and corporate settings.
From 1990 to 1995, Mr. Sly served as vice president, business development for another emerging company, ReSeal Pharmaceutical Systems, directing technological development, business development and marketing of controlled-delivery systems for pharmaceuticals, health care and personal care products.
Mr. Sly received a B.A.
in biology from Pomona College in Claremont, California.
Former positions of Kevin S. Sly
| Companies | Position | End |
|---|---|---|
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Corporate Officer/Principal | 2005-09-14 |
Catalent Maryland, Inc.
 Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Sales & Marketing | - |
Training of Kevin S. Sly
| Pomona College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MiddleBrook Pharmaceuticals, Inc. develops and commercializes anti-infective drug products. It operates mainly in prescription pharmaceuticals. MiddleBrook's main product is PULSYS. PULSYS technology offers the prolonged release and absorption of a drug. The company was incorporated in December 1999 and is headquartered in Westlake, TX. | Health Technology |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
- Stock Market
- Insiders
- Kevin S. Sly
